Skip to main content
Clinical Trials/CTRI/2023/06/054120
CTRI/2023/06/054120
Not yet recruiting
Phase 3

Controlled Clinical Study To Evaluate Efficacy of Amrita Guggulu & Dhatri Nisha Vati In Prameha w.s.r Type-2 Diabetes Mellitus.

Dr Andleev Aaftab0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Sponsor
Dr Andleev Aaftab
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Andleev Aaftab

Eligibility Criteria

Inclusion Criteria

  • 1\) Newly diagnosed patient ( \<2yrs) of Prameha w.r.t
  • type\-2 Diabetes Mellitus.
  • 2\) Subjects of age group b/w 30\-70 yrs (30\-70 both
  • inclusive) will be in the inclusive.
  • 3\) Both male and female (female\- non lactating and
  • not pregnant) will be in the inclusion.
  • 4\) HbA1c \>6\.5 ( \<60mmol/mol) within previous 3
  • 5\) Diabetes Mellitus with F.B.S. \> 126\-mg%,
  • 6\) Post Prandial Blood Sugar \>200mg%.
  • 7\) Written consent showing willingness to participate

Exclusion Criteria

  • 1\) Subjects with Type\-1 Diabetes will be in the exclusion.
  • 2\) Pregnant women, Lactating women will be in the exclusion.
  • 3\) Subjects with creatinine \>1\.5 will be in the exclusion
  • 4\) Fasting blood sugar \>300mg% will be in exclusion.
  • 5\) Post Prandial Blood Sugar \>400mg%.
  • 6\) HbA1c \>9\.0%( \>75mmol/mol) will be in the exclusion criteria.
  • 7\) Subjects with known cases of Diabetic complications like diabetic
  • nephropathy, retinopathy, cardiovascular disease will be in the exclusion.
  • 8\) Subjects with history of stroke, myocardial infarction, in the last 6 months
  • will be in the exclusion.

Outcomes

Primary Outcomes

Not specified

Similar Trials